Latest News

In the past week, Manhattan Associates reported second quarter revenue of US$272.42 million, provided new revenue and earnings guidance for the rest of 2025, promoted Bob Howell to Chief Sales Officer, and announced the completion of a share repurchase tranche. The company's focus on expanding global sales leadership, particularly in large markets like POS and TMS, underscores its ambitions for further market share gains. With new leadership appointments and strong guidance, we'll explore...

Aquarius Surgical Technologies ( CSE:ASTI ) Full Year 2025 Results Key Financial Results Net loss: CA$1.17m (loss...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

W. R. Berkley Corporation recently reported its second quarter 2025 earnings, including year-over-year increases in revenue, net income, and earnings per share, alongside product updates in its Berkley One Classics segment for the Georgia market. These developments not only highlight the company's ongoing financial momentum but also reflect its commitment to evolving specialty insurance offerings and customer-focused coverage enhancements. We'll now examine how the company's strong quarterly...

Over the last 7 days, the United States market has remained flat, yet it has shown a robust performance with a 17% increase over the past year and earnings forecasted to grow by 15% annually. In this environment of steady growth, identifying high growth tech stocks requires focusing on companies that demonstrate innovative capabilities and strong potential for sustained revenue expansion.

Over the last 7 days, the United States market has remained flat, yet it has experienced a notable increase of 17% over the past year with earnings forecasted to grow by 15% annually. In this environment, identifying stocks that are trading at a discount can be an advantageous strategy for investors seeking value opportunities amidst broader market growth.

Red Light Holland ( CSE:TRIP ) Full Year 2025 Results Key Financial Results Revenue: CA$4.94m (up 4.0% from FY 2024...

It hasn't been the best quarter for Merit Medical Systems, Inc. ( NASDAQ:MMSI ) shareholders, since the share price has...

BluSky AI Inc. has announced a significant step in its strategic expansion by signing a non-binding letter of intent to acquire 25 acres of land within Creekstone Energy LLC's Delta Data Center Development. This acquisition will provide BluSky with access to up to 50 megawatts of scalable power, crucial for meeting the increasing demand for efficient and secure AI capabilities. The Delta Gigasite offers a unique advantage due to its location at the convergence of high-density fiber, renewable...

Most readers would already be aware that HEICO's (NYSE:HEI) stock increased significantly by 29% over the past three...

Ridgetech ( NASDAQ:RDGT ) Full Year 2025 Results Key Financial Results Revenue: US$120.0m (down 22% from FY 2024). Net...

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 17%, with earnings forecast to grow by 15% annually. In this context of steady growth, stocks like Niagen Bioscience and others with high insider ownership can be appealing as they often indicate confidence from those closest to the company in its potential for future success.

Earlier this week, Cognizant announced the expansion of its partnership with Lineage, Inc. to drive customer service transformation, introducing Agentic AI technologies and enhanced service models within Lineage's cold chain logistics operations. This initiative highlights Lineage's commitment to streamlined solutions and the preservation of trusted client relationships amid a broader push for digital innovation in customer care. We'll explore how integrating advanced AI-powered customer...

Key Insights Given the large stake in the stock by institutions, Inhibikase Therapeutics' stock price might be...

Over the last 7 days, the market has remained flat, but it is up 17% over the past year with earnings forecasted to grow by 15% annually. In such a landscape, identifying stocks that combine affordability with growth potential can be particularly rewarding. Although 'penny stocks' might seem like a term from another era, they continue to offer opportunities for investors seeking smaller or newer companies with strong financials and promising prospects.

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Brixmor Property Group recently reported its second-quarter 2025 results, highlighting increased sales of US$339.4 million and net income of US$85.14 million, alongside an updated full-year earnings guidance and a reaffirmed quarterly dividend. An interesting detail is that while the company achieved higher quarterly sales and net income versus a year ago, its six-month net income was slightly lower, indicating some variability in performance across reporting periods. We'll review how...

The United States market has shown resilience, remaining flat over the last week but boasting a 17% increase over the past year with projected annual earnings growth of 15%. In such an environment, identifying stocks that are not only underappreciated but also poised to benefit from these positive trends can be key to uncovering potential opportunities.

A number of AtriCure, Inc. ( NASDAQ:ATRC ) insiders sold their shares in the last year, which may have raised concerns...

TriMas ( NASDAQ:TRS ) Second Quarter 2025 Results Key Financial Results Revenue: US$274.8m (up 14% from 2Q 2024). Net...

Omega Healthcare Investors recently declared a cash dividend of US$0.67 per share on its common stock, with payment scheduled for August 15, 2025, to shareholders on record as of August 4, 2025. This dividend declaration may signal the company's confidence in its financial stability and ongoing commitment to returning value to shareholders. We'll examine how this latest dividend announcement supports Omega Healthcare Investors' income-focused investment narrative and outlook. Uncover the...

In the last week, the United States market has stayed flat; however, over the past 12 months, it has risen by an impressive 17%, with earnings expected to grow by 15% per annum in the coming years. In this context of steady growth and optimistic projections, identifying strong dividend stocks can be a strategic move for investors seeking reliable income streams alongside potential capital appreciation.

MEDIROM Healthcare Technologies Inc. ( NASDAQ:MRM ), might not be a large cap stock, but it received a lot of attention...

Hubbell ( NYSE:HUBB ) Second Quarter 2025 Results Key Financial Results Revenue: US$1.48b (up 2.2% from 2Q 2024). Net...